Expert: Coronavirus Vaccine Trial Pause Is Normal Part of Process Sept. 11, 2020 AstraZeneca and the University of Oxford have put their combined Phase 2 and 3 trial on standby after one United Kingdom participant reportedly developed severe neurological symptoms. The volunteer's condition and what brought it on remain unclear. University of Arizona immunologist Deepta Bhattacharya at the College of Medicine – Tucson, said such questions are the point of large human trials. "As we start to expand out the numbers into tens of thousands of people, will we start to see some rare events, and what is the risk-reward proposition once you start to see that data?" KJZZ-FM (NPR) Phoenix
Green Light Therapy Reduces Migraine Pain Sept. 11, 2020 New research is shining a light on an unusual treatment for migraine headaches: green light therapy. In a small study involving 29 migraine patients, University of Arizona Health Sciences researchers found that exposure to green light for one to two hours daily reduced headache pain by 60% and significantly reduced the frequency of migraines. Pain News Network
New Guided Imagery App from UArizona Nursing Researcher to Help Reduce Stress and Anxiety of Social Isolation in Pandemic Sept. 10, 2020 Dr. Judith Gordon’s research team develops “See Me Serene” project with BIO5 Institute seed funding. Now available free via the App Store and Google Play, it aims to aid people’s mental and physical health. Read more Image
An Inside Look at Mentoring in a Pharmacy Lab Sept. 10, 2020 Health Sciences researchers are recognized for mentoring students in the lab. Here’s a look at how one PI guides a graduate research assistant. Read more Image
Green Light Therapy Shown to Reduce Migraine Frequency, Intensity Sept. 10, 2020 New research from the University of Arizona Health Sciences found that people who suffer from migraine may benefit from green light therapy, which was shown to reduce the frequency and intensity of headaches and improve patient quality of life. Science Daily
Is It Safe to Get a Haircut? Here Are the Risks of 5 Everyday Activities During COVID-19 Sept. 10, 2020 In general, deciding whether to take part in an activity is “not one size fits all,” said Dr. Shad Marvasti, director of public health at the University of Arizona College of Medicine-Phoenix. He said anyone who could be considered a vulnerable individual, such as someone who has a chronic disease or compromised immune system, should consider how essential it is to take part in a potentially risky activity. Arizona Republic
Shining a Green Light on a New Preventive Therapy for Migraine Sept. 9, 2020 People who suffer from migraine are reducing their pain and improving their quality of life thanks to pain specialists at the University of Arizona Health Sciences and their green light research. Read more Image
Green Light Therapy Shown to Reduce Migraine Frequency, Intensity Sept. 9, 2020 A study by University of Arizona Health Sciences researchers found that green light therapy resulted in about a 60% reduction in the pain intensity of the headache phase and number of days per month people experienced migraine headaches. Read more Image
University COVID Cases Sept. 9, 2020 Report on the number of COVID cases among students at Arizona’s three state universities. Dr. Shad Marvasti from the University of Arizona College of Medicine says the amount of partying among students is a concern. KPHO-TV (CBS) Phoenix
'Brain Fog' One Of the Lingering Symptoms Of COVID-19 Sept. 9, 2020 Many individuals recovering from COVID-19 are experiencing lingering symptoms that can last for weeks. One post-viral symptom is something called "brain fog." Dr. Shad Marvasti, an associate professor and director of public health and prevention curriculum at the University of Arizona College of Medicine in Phoenix, explains the symptoms of brain fog. KJZZ-FM (NPR) Phoenix